Senior Valuations & IPV Lead, OTC Exotics

Senior Valuations & IPV Lead, OTC Exotics

Full-Time 60000 - 75000 Β£ / year (est.) No working from home possible
O

At a Glance

  • Tasks: Lead independent valuation and pricing controls for OTC exotic derivatives.
  • Company: Optiver, a leading trading firm in London with a focus on innovation.
  • Benefits: Competitive salary, dynamic work environment, and opportunities for professional growth.
  • Other info: Join a collaborative team at the forefront of financial technology.
  • Why this job: Shape the future of trading by ensuring accurate valuations and driving automation.
  • Qualifications: Experience in valuations control and strong analytical skills required.

The predicted salary is between 60000 - 75000 Β£ per year.

Optiver in London seeks a senior Valuations Control Specialist to lead independent valuation and pricing controls for OTC exotic derivatives. This role sits at the intersection of Finance and Middle Office, defining standards, building infrastructure and ensuring defensible, audit-ready valuations as the OTC book scales.

You will own IPV for OTC exotics, develop methodologies and work with Trading, Quant Research and Technology to automate workflows while maintaining strong governance.

Senior Valuations & IPV Lead, OTC Exotics employer: Optiver

Optiver is an exceptional employer, offering a dynamic and collaborative work culture in the heart of London. As a Valuations Specialist, you will thrive in an environment that prioritises continuous improvement and professional growth, supported by comprehensive benefits such as a performance-based bonus structure, generous vacation days, and opportunities for international career advancement. Join a team of curious thinkers and creative problem solvers dedicated to enhancing market efficiency and transparency.

O

Contact Details:

Optiver Recruitment Team

We think you need these skills to ace Senior Valuations & IPV Lead, OTC Exotics

Valuation Control
Pricing Controls
OTC Exotic Derivatives
Methodology Development
Governance
Audit-Ready Valuations
Collaboration with Trading